Cephalon

Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash Cephalon To Buy ChemGenex Pharmac For A$225 Mln In Cash (CEPH) Modavigil: A case study in smart drugs. Valeant bids US$5.7B for Cephalon Valeant Pharmaceuticals International Inc., the reincarnation of the former Canadian drug powerhouse. Valeant offering to buy Cephalon for $5.7B | The Daily Caller … Valeant Pharmaceuticals Inc. says it has offered to acquire biopharmaceutical company Cephalon Inc. for $5.7 billion in cash. The proposed bid by Mississauga, Cephalon update | ChemGenex Pharmaceuticals – Targeted Medicine MELBOURNE, Australia, and MENLO PARK, California U.S.A. (30 March 2011). ChemGenex Pharmaceuticals Limited (ASX: CXS) (ChemGenex) has today become aware that. Cephalon in Acquisition Mode | FavStocks Cephalon , Inc. (CEPH) recently announced its intention to acquire Australian biopharma company ChemGenex Pharmaceuticals Limited. Cephalon extended an offer. Cephalon Acquired by Valeant Pharmaceuticals in USD 5.7 Billion … Cephalon Inc, the biopharmaceutical company has been acquired by Canada Valeant Pharmaceuticals Inc in cash USD5.7 billion. Valeant resorted to airing out its. catleungbuzzbox says: Cephalon – Valeant Pharmaceuticals International on 3 Fav Sources+13 others like The Street-Valeant Goes Hostile… http://bit.ly/fxkftS

Posted by on March 30, 2011. Filed under News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.